parallel sessions - International Society for Blood Transfusion

PostersISBT2006PostersTOPIC 04.2The posters areon display fromMonday - ThursdayTOPIC 04.2P-368 THE EFFICACY OF PHOTOCHEMICAL TREATMENT WITH AMOTOSALENAND UVA (INTERCEPTTM) FOR THE INACTIVATION OF TRYPANOSOMECRUZI (T.CRUZI) IN BUFFY COAT DERIVED PLATELET COMPONENTSE. Castro, N. Girones, J.L. Bueno, J. Carrion, M. Fresno (Centro de Transfusión Cruz RojaEspañola, Madrid, Spain)P-377 INACTIVATION OF HIGH LEVELS OF BACTERIA USING THE INTER-CEPT BLOOD SYSTEM UNDER ROUTINE BLOOD BANK PROCEDURESA. Ontanon, I. Romon, C. Hurtado, J. Hsu, L. Lin, V. Hermosa (Banco de Sangre deCantabria, Santander, Spain)P-369 THERAPEUTIC EFFICACY AND SAFETY OF TRANSFUSION OFPATHOGEN-INACTIVATED PLATELETS TO PEDIATRIC PATIENTSL. Van Haute, Y. Benoit, V. Bordon, B. De Moerloose, E. Vandecruys, S. Van Lancker,M. Van Vooren, B. Vandekerckhove (Red Cross Flanders, Gent, Belgium)P-378 IMPACT OF PHOTOCHEMICAL TREATMENT (INTERCEPT)ON PLATELET USE IN ROUTINE PRACTICEJ.C. Osselaer, C. Doyen, C. Chatelain, C. Debry, M. Goffaux, N. Messe, M. van Hooydonk,A. Sonnet, A. Bosly, J.S. Lin, L. Corash (Cliniques Universitaires de Mont Godinne, Yvoir,Belgium)P-370 PATHOGEN INACTIVATION OF TRYPANOSOMA CRUZI IN PLATELETCONCENTRATES WITH RIBOFLAVIN AND UV LIGHTL.J. Cardo, J. Salata, J. Mendez, H. Reddy, R. Goodrich (Walter Reed Army Institute ofResearch, Silver Spring, United States of America)P-379 A PROSPECTIVE OBSERVATIONAL COHORT SAFETY STUDY OF5,106 PLATELET TRANSFUSIONS PREPARED WITH PHOTOCHEMICALTREATMENT (INTERCEPT)J.C. Osselaer, N. Messe, T. Hervig, J.L. Bueno, E. Castro, A. Espinosa, A. Iacone, K. Junge,M. Jacquet, J. Flament, L. Corash (Cliniques Universitaires de Mont Godinne, Yvoir, Belgium)114P-371 AGITATION DURING TREATMENT IMPROVES THE INACTIVATION OFPATHOGENS IN PLATELET CONCENTRATES BY UVB IRRADIATIONH. Mohr, A. Bayer, F. Tolksdorf, W.H. Walker, T.H. Mueller (Blood Center of the German RedCross, Springe, Germany)P-380 ROUTINE PRODUCTION OF INTERCEPT-TREATED APHERESISPLATELET CONCENTRATES FOR PEDIATRIC PATIENTSM. Stiegler, V Witt, P Mörtl, G Leitner, P Höcker (Medical University of Vienna, Vienna, Austria)115P-372 TRANSFUSION OF PATHOGEN INACTIVATED PLATELETCONCENTRATES IN CHILDRENV.W. Witt, G. Stiegler, P. Höcker, C. Peters, H. Gadner (St. Anna Kinderspital, Vienna, Austria)P-374 STORAGE OF APHERESIS AND POOLED BUFFY-COAT PLATELETCONCENTRATES TREATED WITH PATHOGEN INACTIVATION USING THEINTERCEPT BLOOD SYSTEMP. Schlenke, V. Franck, L. Lin, H. Kirchner (University Lübeck School of Medicine, Lübeck,Germany)Topic 04.3.Pathogen Reduction/Inactivation - PlasmaP-381 QUALITY OF METHYLENE BLUE PLASMA OVER THE LAST FIVEYEARSA. Castrillo, A. Eiras, J. Cid, A. Castro, M. Adelantado, M. Abalo, C. Areal, J. Flores,J. Cabrera (Centro de Transfusion de Galicia, Santiago De Compostela, Spain)P-375 EVALUATION OF THE INTERCEPT BLOOD SYSTEM FOR AMICUSAPHERESIS PLATELET CONCENTRATES: MEETING TARGET PRODUCTCHARACTERISTICSM. Lambermont, R. de Meuter, G. Bastin (Service du Sang, Belgian Red Cross, Brussels, Belgium)P-382 COMPARATIVE STUDY OF TREATED AND UNTREATED FRESHFROZEN PLASMA AS SOURCE OF FIBRINOGEN CONCENTRATESOBTAINED FROM METHYLENE BLUE TREATED PLASMA FROMMACO PHARMA MACO-TRONIC SYSTEME. Lachert, J. Kubis, J. Antoniewicz-Papis, A. Goller, M. Letowska, G. Kulla(Institute of Hematology, Warsaw, Poland)P-376 PHOTOCHEMICAL PATHOGEN INACTIVATION OF HIGH-DOSE APHERESISPLATELET CONCENTRATES USING THE INTERCEPT BLOOD SYSTEMJ.C. Osselaer, C. Debry, M. Goffaux, M. van Hooydonk, V. Mayaudon, L. Lin, L. Corash(Mont-Godinne University Hospital, Yvoir, Belgium)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT